The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $87.50

Today's change0.00 0.00%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

Charles River Laboratories International Inc

NYSE: CRL
Last

(U.S.) $87.50

Today's change0.00 0.00%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

Charles River Laboratories International Inc closed at (U.S.)$87.50.

Over the last five days, shares have gained 1.73% and 8.84% year to date. Shares have outperformed the S&P 500 by 10.93% during the last year.

Key company metrics

  • Open(U.S.) $86.96
  • Previous close(U.S.) $87.50
  • High(U.S.) $87.71
  • Low(U.S.) $86.42
  • Bid / Ask-- / --
  • YTD % change+8.84%
  • Volume265,444
  • Average volume (10-day)275,996
  • Average volume (1-month)338,199
  • Average volume (3-month)405,100
  • 52-week range(U.S.) $59.99 to (U.S.) $87.98
  • Beta1.29
  • Trailing P/E26.69×
  • P/E 1 year forward19.82×
  • Forward PEG1.63×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.28
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.30%

Based on its net profit margin of 11.30%, Charles River Laboratories International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 26, 201603/26/2016Dec 26, 201512/26/2015Sep 26, 201509/26/2015Jun 27, 201506/27/2015
Revenue355354349340
Total other revenue--------
Total revenue355354349340
Gross profit141141138133
Total cost of revenue214213211207
Total operating expense303302294284
Selling / general / administrative83817671
Research & development--------
Depreciation / amortization6766
Interest expense (income), net operating--------
Unusual expense (income)------1
Other operating expenses, total--------
Operating income51525556
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax52505360
Income after tax38333849
Income tax, total14171511
Net income37323749
Total adjustments to net income--------
Net income before extra. items37333749
Minority interest000-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items37333749
Inc. avail. to common incl. extra. items37323749
Diluted net income37323749
Dilution adjustment--0----
Diluted weighted average shares48484748
Diluted EPS excluding extraordinary itemsvalue per share0.780.690.791.02
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.780.690.791.03